Advertisement

The Role of Vascular Risk Factors in Cognitive Impairment and Dementia and Prospects for Prevention

Published:October 18, 2022DOI:https://doi.org/10.1016/j.cger.2022.07.007

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Geriatric Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jongsiriyanyong S.
        • Limpawattana P.
        Mild cognitive impairment in clinical practice: a review article.
        Am J Alzheimers Dis Other Demen. 2018; 33: 500-507
        • Gorelick P.B.
        • Furie K.L.
        • Iadecola C.
        • et al.
        Defining optimal brain health in adults: a presidential advisory from the American heart association/American stroke association.
        Stroke. 2017; 48: e284-e303
        • Lazar R.M.
        • Howard V.J.
        • Kernan W.N.
        • et al.
        A primary care agenda for brain health: a scientific statement from the American heart association.
        Stroke. 2021; 52: e295-e308
        • US Department of Health and Human Services
        National plan to address Alzheimer’s disease: 2021 update.
        2021 (Available at:) (Accessed December 29, 2021)
        • Gorelick P.B.
        Vascular cognitive impairment.
        in: Lazar R.M. Browndyke J.N. Pond M.A. Neurovascular neuropsychology. 2nd ed. Springer, Cham2020: 121-138
        • Gorelick P.B.
        • Mangone C.A.
        Vascular dementias in the elderly.
        Clin Geriatr Med. 1991; 7: 599-615
        • Hachinski V.
        • Einhaupl K.
        • Ganten D.
        • et al.
        Preventing dementia by preventing stroke: the Berlin Manifesto.
        Alzheimers Dement. 2019; 15: 961-984
        • Willcox B.J.
        • He Q.
        • Chen R.
        • et al.
        Midlife risk factors and healthy survival in men.
        JAMA. 2006; 296: 2343-2350
        • Elias M.F.
        • Sullivan L.M.
        • D'Agostino R.B.
        • et al.
        Framingham stroke risk profile and lowered cognitive performance.
        Stroke. 2004; 35: 404-409
        • Casserly I.
        • Topol E.
        Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins.
        Lancet. 2004; 363: 1139-1146
        • Gottesman R.F.
        • Schneider A.L.
        • Zhou Y.
        • et al.
        Association between midlife vascular risk factors and estimated brain amyloid deposition.
        JAMA. 2017; 317: 1443-1450
        • Lane C.A.
        • Barnes J.
        • Nicholas J.M.
        • et al.
        Associations between vascular risk across adulthood and brain pathology in late life: evidence from a British birth cohort.
        JAMA Neurol. 2020; 77: 175-183
        • Rabin J.S.
        • Klein H.
        • Kirn D.R.
        • et al.
        Associations of physical activity and beta-amyloid with longitudinal cognition and neurodegeneration in clinically normal older adults.
        JAMA Neurol. 2019; 76: 1203-1210
        • Vemuri P.
        • Lesnick T.G.
        • Przybelski S.A.
        • et al.
        Age, vascular health, and Alzheimer disease biomarkers in an elderly sample.
        Ann Neurol. 2017; 82: 706-718
        • Iadecola C.
        • Yaffe K.
        • Biller J.
        • et al.
        Impact of hypertension on cognitive function: a scientific statement from the American heart association.
        Hypertension. 2016; 68: e67-e94
      1. National Academies of Sciences E, and medicine; health and medicine division; board on health Sciences policy; committee on preventing dementia and cognitive impairment.
        in: Downey A. Stroud C. Landis S. Preventing cognitive decline and dementia: a way forward. National Academies Press (US), Washington, DC2017
        • Livingston G.
        • Sommerlad A.
        • Orgeta V.
        • et al.
        Dementia prevention, intervention, and care.
        Lancet. 2017; 390: 2673-2734
        • Livingston G.
        • Huntley J.
        • Sommerlad A.
        • et al.
        Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.
        Lancet. 2020; 396: 413-446
        • Unger T.
        • Borghi C.
        • Charchar F.
        • et al.
        2020 International society of hypertension global hypertension practice guidelines.
        Hypertension. 2020; 75: 1334-1357
        • Mahinrad S.
        • Sorond F.A.
        • Gorelick P.B.
        Hypertension and cognitive dysfunction: a review of mechanisms, life-course observational studies and clinical trial results.
        Rev Cardiovasc Med. 2021; 22: 1429-1449
        • Iadecola C.
        • Gottesman R.F.
        Neurovascular and cognitive dysfunction in hypertension.
        Circ Res. 2019; 124: 1025-1044
        • Gottesman R.F.
        • Schneider A.L.
        • Albert M.
        • et al.
        Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study.
        JAMA Neurol. 2014; 71: 1218-1227
        • Yaffe K.
        • Vittinghoff E.
        • Pletcher M.J.
        • et al.
        Early adult to midlife cardiovascular risk factors and cognitive function.
        Circulation. 2014; 129: 1560-1567
        • Mahinrad S.
        • Kurian S.
        • Garner C.R.
        • et al.
        Cumulative blood pressure exposure during young adulthood and mobility and cognitive function in midlife.
        Circulation. 2020; 141: 712-724
        • Peters R.
        • Peters J.
        • Booth A.
        • et al.
        Trajectory of blood pressure, body mass index, cholesterol and incident dementia: systematic review.
        Br J Psychiatry. 2020; 216: 16-28
        • Organization WH
        Risk reduction of cognitive decline and dementia.
        WHO guidelines, Geneva2019
        • Biessels G.J.
        • Despa F.
        Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications.
        Nat Rev Endocrinol. 2018; 14: 591-604
        • Koekkoek P.S.
        • Kappelle L.J.
        • van den Berg E.
        • et al.
        Cognitive function in patients with diabetes mellitus: guidance for daily care.
        Lancet Neurol. 2015; 14: 329-340
        • Luchsinger J.A.
        • Reitz C.
        • Patel B.
        • et al.
        Relation of diabetes to mild cognitive impairment.
        Arch Neurol. 2007; 64: 570-575
        • Gudala K.
        • Bansal D.
        • Schifano F.
        • et al.
        Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies.
        J Diabetes Investig. 2013; 4: 640-650
        • Zhang J.
        • Chen C.
        • Hua S.
        • et al.
        An updated meta-analysis of cohort studies: diabetes and risk of Alzheimer's disease.
        Diabetes Res Clin Pract. 2017; 124: 41-47
        • Areosa Sastre A.
        • Vernooij R.W.
        • Gonzalez-Colaco Harmand M.
        • et al.
        Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia.
        Cochrane Database Syst Rev. 2017; 6: CD003804
        • Brenowitz W.D.
        Invited commentary: body mass index and risk of dementia-potential Explanations for life-course differences in risk estimates and Future research directions.
        Am J Epidemiol. 2021; 190: 2511-2514
        • Albanese E.
        • Launer L.J.
        • Egger M.
        • et al.
        Body mass index in midlife and dementia: systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies.
        Alzheimers Dement (Amst). 2017; 8: 165-178
        • Qu Y.
        • Hu H.Y.
        • Ou Y.N.
        • et al.
        Association of body mass index with risk of cognitive impairment and dementia: a systematic review and meta-analysis of prospective studies.
        Neurosci Biobehav Rev. 2020; 115: 189-198
        • Kivimaki M.
        • Luukkonen R.
        • Batty G.D.
        • et al.
        Body mass index and risk of dementia: analysis of individual-level data from 1.3 million individuals.
        Alzheimers Dement. 2018; 14: 601-609
        • Singh-Manoux A.
        • Dugravot A.
        • Shipley M.
        • et al.
        Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study.
        Alzheimers Dement. 2018; 14: 178-186
        • Veronese N.
        • Facchini S.
        • Stubbs B.
        • et al.
        Weight loss is associated with improvements in cognitive function among overweight and obese people: a systematic review and meta-analysis.
        Neurosci Biobehav Rev. 2017; 72: 87-94
        • Power M.C.
        • Rawlings A.
        • Sharrett A.R.
        • et al.
        Association of midlife lipids with 20-year cognitive change: a cohort study.
        Alzheimers Dement. 2018; 14: 167-177
        • Anstey K.J.
        • Ashby-Mitchell K.
        • Peters R.
        Updating the evidence on the association between serum cholesterol and risk of late-life dementia: review and meta-analysis.
        J Alzheimers Dis. 2017; 56: 215-228
        • Bunt C.W.
        • Hogan A.J.
        The effect of statins on dementia and cognitive decline.
        Am Fam Physician. 2017; 95: 151-152
        • Durazzo T.C.
        • Mattsson N.
        • Weiner M.W.
        Alzheimer's Disease Neuroimaging I. Smoking and increased Alzheimer's disease risk: a review of potential mechanisms.
        Alzheimers Dement. 2014; 10: S122-S145
        • Sabia S.
        • Elbaz A.
        • Dugravot A.
        • et al.
        Impact of smoking on cognitive decline in early old age: the Whitehall II cohort study.
        Arch Gen Psychiatry. 2012; 69: 627-635
        • Zhong G.
        • Wang Y.
        • Zhang Y.
        • et al.
        Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers.
        PLoS One. 2015; 10: e0118333
        • Chang C.C.
        • Zhao Y.
        • Lee C.W.
        • et al.
        Smoking, death, and Alzheimer disease: a case of competing risks.
        Alzheimer Dis Assoc Disord. 2012; 26: 300-306
        • Weuve J.
        • Tchetgen Tchetgen E.J.
        • Glymour M.M.
        • et al.
        Accounting for bias due to selective attrition: the example of smoking and cognitive decline.
        Epidemiology. 2012; 23: 119-128
        • Cataldo J.K.
        • Prochaska J.J.
        • Glantz S.A.
        Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation.
        J Alzheimers Dis. 2010; 19: 465-480
        • Deal J.A.
        • Power M.C.
        • Palta P.
        • et al.
        Relationship of cigarette smoking and time of quitting with incident dementia and cognitive decline.
        J Am Geriatr Soc. 2020; 68: 337-345
        • Erickson K.I.
        • Donofry S.D.
        • Sewell K.R.
        • et al.
        Cognitive aging and the promise of physical activity.
        Annu Rev Clin Psychol. 2022; 18: 417-442
        • Kivimaki M.
        • Singh-Manoux A.
        • Pentti J.
        • et al.
        Physical inactivity, cardiometabolic disease, and risk of dementia: an individual-participant meta-analysis.
        BMJ. 2019; 365: l1495
        • Sofi F.
        • Valecchi D.
        • Bacci D.
        • et al.
        Physical activity and risk of cognitive decline: a meta-analysis of prospective studies.
        J Intern Med. 2011; 269: 107-117
        • Palta P.
        • Sharrett A.R.
        • Deal J.A.
        • et al.
        Leisure-time physical activity sustained since midlife and preservation of cognitive function: the Atherosclerosis Risk in Communities Study.
        Alzheimers Dement. 2019; 15: 273-281
        • Pistollato F.
        • Iglesias R.C.
        • Ruiz R.
        • et al.
        Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer's disease: a focus on human studies.
        Pharmacol Res. 2018; 131: 32-43
        • Jennings A.
        • Cunnane S.C.
        • Minihane A.M.
        Can nutrition support healthy cognitive ageing and reduce dementia risk?.
        BMJ. 2020; 369: m2269
        • Radd-Vagenas S.
        • Duffy S.L.
        • Naismith S.L.
        • et al.
        Effect of the Mediterranean diet on cognition and brain morphology and function: a systematic review of randomized controlled trials.
        Am J Clin Nutr. 2018; 107: 389-404
        • Group S.R.
        • Lewis C.E.
        • Fine L.J.
        • et al.
        Final report of a trial of intensive versus standard blood-pressure control.
        N Engl J Med. 2021; 384: 1921-1930
        • Group SMIftSR
        • Williamson J.D.
        • Pajewski N.M.
        • et al.
        Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial.
        JAMA. 2019; 321: 553-561
        • Group SMIftSR
        • Nasrallah I.M.
        • Pajewski N.M.
        • et al.
        Association of intensive vs standard blood pressure control with cerebral white matter lesions.
        JAMA. 2019; 322: 524-534
        • Nasrallah I.M.
        • Gaussoin S.A.
        • Pomponio R.
        • et al.
        Association of intensive vs standard blood pressure control with magnetic resonance imaging biomarkers of alzheimer disease: secondary analysis of the SPRINT MIND randomized trial.
        JAMA Neurol. 2021; 78: 568-577
        • Forette F.
        • Seux M.L.
        • Staessen J.A.
        • et al.
        The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.
        Arch Intern Med. 2002; 162: 2046-2052
        • Tzourio C.
        • Anderson C.
        • Chapman N.
        • et al.
        Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease.
        Arch Intern Med. 2003; 163: 1069-1075
        • Gorelick P.B.
        Prevention of cognitive impairment: scientific guidance and windows of opportunity.
        J Neurochem. 2018; 144: 609-616
        • Williamson J.D.
        • Launer L.J.
        • Bryan R.N.
        • et al.
        Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial.
        JAMA Intern Med. 2014; 174: 324-333
        • Ngandu T.
        • Lehtisalo J.
        • Solomon A.
        • et al.
        A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.
        Lancet. 2015; 385: 2255-2263
        • Ryan J.
        • Storey E.
        • Murray A.M.
        • et al.
        Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.
        Neurology. 2020; 95: e320-e331
        • Peters R.
        • Warwick J.
        • Anstey K.J.
        • et al.
        Blood pressure and dementia: what the SPRINT-MIND trial adds and what we still need to know.
        Neurology. 2019; 92: 1017-1018
        • Peters R.
        • Yasar S.
        • Anderson C.S.
        • et al.
        Investigation of antihypertensive class, dementia, and cognitive decline: a meta-analysis.
        Neurology. 2020; 94: e267-e281
        • Marcum Z.A.
        • Cohen J.B.
        • Zhang C.
        • et al.
        Association of antihypertensives that stimulate vs inhibit types 2 and 4 angiotensin II receptors with cognitive impairment.
        JAMA Netw Open. 2022; 5: e2145319
        • Gorelick P.B.
        • Sorond F.
        Cognitive function in SPRINT: where do we go next?.
        Lancet Neurol. 2020; 19: 880-881
        • Dolui S.
        • Detre J.A.
        • Gaussoin S.A.
        • et al.
        Association of intensive vs standard blood pressure control with cerebral blood flow: secondary analysis of the SPRINT MIND randomized clinical trial.
        JAMA Neurol. 2022; 79: 380-389
        • Gorelick P.B.
        • Whelton P.K.
        • Sorond F.
        • et al.
        Blood pressure management in stroke.
        Hypertension. 2020; 76: 1688-1695